Figure 3. OS and tumor recurrence after liver resection for patients with different risk scores in the primary and validation cohorts.

(A, B) OS and tumor recurrence in the primary cohort; (p < 0.001 for both) (C, D) OS and tumor recurrence in the validation cohort. (p < 0.001 for both).